rethinkPeptides Search
Menu
Research citation

WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides.

American journal of hematology, 90(7), 602-7

Citation

Brayer, Jason; Lancet, Jeffrey E; Powers, John; List, Alan; Balducci, Lodovico; Komrokji, Rami; Pinilla-Ibarz, Javier. (2015). WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides.. American journal of hematology, 90(7), 602-7. https://doi.org/10.1002/ajh.24014